1. Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus

   • Carlo Amorin Daep
   • Jorge L. Muñoz-Jordán
   • Eliseo Alberto Eugenin

   Review 07 October 2014 Pages: 539 - 560

   

2. Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment

   • Jordan E. Cattie
   • Scott L. Letendre
   • The Translational Methamphetamine AIDS Research Center (TMARC) Group

   OriginalPaper 18 October 2014 Pages: 561 - 570

   

3. Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)

   • Lishomwa C. Ndhlovu
   • Tracie Umaki
   • Cecilia M. Shikuma

   OriginalPaper 17 September 2014 Pages: 571 - 582

   

4. Atrophy, focal spinal cord lesions and alterations of diffusion tensor imaging (DTI) parameters in asymptomatic virus carriers and patients suffering from human T-lymphotrophic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

   • Carlos Vilchez
   • Massiel Gonzalez-Reinoso
   • Peter Stoeter

   OriginalPaper 17 September 2014 Pages: 583 - 590

   

5. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease

   • Kelly A. Meulendyke
   • Suzanne E. Queen
   • M. Christine Zink

   OriginalPaper 17 September 2014 Pages: 591 - 602

   

6. Brain morphometric correlates of metabolic variables in HIV: the CHARTER study

   • S. L. Archibald
   • J. A. McCutchan
   • for the CHARTER Group

   OriginalPaper 17 September 2014 Pages: 603 - 611

   

7. Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb

   • Chun-Xia Li
   • Xiaodong Zhang
   • Francis J. Novembre

   OriginalPaper 07 November 2014 Pages: 612 - 619

   

8. Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment

   • Ned Sacktor
   • Sachiko Miyahara
   • on behalf of the ACTG A5235 team

   OriginalPaper 07 November 2014 Pages: 620 - 626

9. Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease

   • Robert H. Paul
   • John A. Joska
   • Dan J. Stein

   OriginalPaper 01 November 2014 Pages: 627 - 635

   

10. Human T-lymphotropic virus type 2 subtype b in a patient with chronic neurological disorder

    • Carolina Rosadas
    • Ana C. P. Vicente
    • Marzia Puccioni-Sohler

    Case Report 03 September 2014 Pages: 636 - 639

    

11. Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man

    • Joshua Chalkley
    • Joseph R. Berger

    Case Report 01 November 2014 Pages: 640 - 643

    

12. 2014 Colorado alphaherpesvirus latency symposium

    • Randall J. Cohrs
    • Don Gilden

    Guest Editorial 05 November 2014 Pages: 644 - 656